导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 15.82% | 457/4773 |
| 近一周 | -0.27% | 209/5462 |
| 近一月 | 6.00% | 78/5421 |
| 近一季 | 6.81% | 246/5209 |
| 近半年 | 18.83% | 171/4920 |
| 近一年 | 23.02% | 350/4366 |
| 近两年 | 82.40% | 792/2954 |
| 近三年 | 106.91% | 123/2253 |
| 成立以来 | 80.23% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
0.55% 1509/4961 |
-0.26% 3273/5312 |
- - |
- - |
| 2025 | 34.16% 1074/4813 |
11.69% 269/3635 |
11.23% 203/4076 |
-0.63% 3934/4524 |
8.68% 230/4813 |
| 2024 | 33.62% 68/3463 |
3.98% 492/2808 |
14.03% 14/3014 |
3.84% 2915/3129 |
8.52% 390/3463 |
| 2023 | 1.02% 374/2656 |
-0.50% 1798/2280 |
7.21% 33/2385 |
-5.91% 1395/2515 |
0.65% 135/2655 |
| 2022 | 5.52% 18/2207 |
9.05% 11/1919 |
0.35% 1557/2016 |
-11.69% 558/2113 |
9.18% 233/2208 |
| 2021 | 3.28% 619/1822 |
13.26% 10/1255 |
-3.94% 1254/1330 |
-4.89% 745/1466 |
-0.20% 1212/1822 |
| 2020 | -17.28% 1005/1250 |
- - |
- - |
- - |
- - |
| 2019 | 6.42% 740/1092 |
- - |
- - |
- - |
- - |
| 2018 | -6.06% 62/834 |
- - |
- - |
- - |
- - |
| 2017 | 16.85% 232/714 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 鹏华香港银行指数(LOF)A VS. 长安沪深300非周期A(740101) |